Orion Oyj (OTCMKTS:ORINF) Sees Large Drop in Short Interest

Orion Oyj (OTCMKTS:ORINF) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 283,700 shares, a decline of 54.5% from the February 28th total of 623,300 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 2,837.0 days.

Orion Oyj Price Performance

ORINF stock remained flat at $48.65 during trading on Friday. The company’s 50 day moving average price is $48.65 and its 200 day moving average price is $48.07. Orion Oyj has a 12-month low of $48.65 and a 12-month high of $48.65.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.